5 Results for "

malignant ascites

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "malignant ascites" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-125120
CAS No.: 133898-77-8
Purity:  99.02%
Kansuiphorin C ameliorates malignant ascites by modulating gut microbiota and related metabolic functions .
loading...
    loading...
Cat. No.: HY-P9954
CAS No.: 509077-98-9

Target:  

CD3

Research Areas:  

Cancer

Catumaxomab, a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab region has binding affinity for FcγR1 (CD 64), FcγRIIA (CD 32a), and FcγRIII (CD 16). Catumaxomab can be used for anti-tumor research, especially epithelial cancers .
loading...
    loading...
Cat. No.: HY-P99262
CAS No.: 1430205-07-4
Synonyms: BAX69; Anti-Human MIF Recombinant Antibody

Research Areas:  

Cancer

Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF). Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer .
loading...
    loading...
Cat. No.: HY-P991526
CAS No.: 2933295-42-0

Target:  

CD3

Research Areas:  

Cancer

M701 is a T-cell engager bispecific humanized antibody targeting epithelial cell adhesion molecule (EpCAM) and cluster of differentiation 3 (CD3). M701 binds to EpCAM on tumor cells and CD3 on T cells, thereby linking the two cell populations to achieve targeted cytotoxicity and T cell-mediated cytotoxicity. M701 is applicable to research related to advanced epithelial solid tumors .
loading...
    loading...
Cat. No.: HY-N19312
CAS No.: 28164-57-0
Diospyrin is a dinaphthoquinone anticancer agent with pro-apoptotic (apoptosis) activity, glutathione S-transferase (Glutathione S-transferase) inhibitory activity, and topoisomerase (Topoisomerase) I inhibitory activity. Diospyrin is present in the heartwood of various Diospyros plants and can be used for research on Ehrlich ascites carcinoma, acute myeloid leukemia, chronic myeloid leukemia, mammary adenocarcinoma, cervical epithelial carcinoma, malignant cutaneous melanoma, laryngeal epidermoid carcinoma, human osteosarcoma, and human lymphoblastic carcinoma .
loading...
    loading...